BI-3802
≥99%
- Product Code: 57588
CAS:
2166387-65-9
| Molecular Weight: | 484.98 g./mol | Molecular Formula: | C₂₄H₂₉ClN₆O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
BI-3802 is a small molecule inhibitor that targets BCL6, a transcriptional repressor involved in the regulation of gene expression. Its primary application is in cancer research and therapy, particularly for treating B-cell lymphomas. By inhibiting BCL6, BI-3802 disrupts the protein's ability to promote cancer cell survival and proliferation, leading to the induction of apoptosis in malignant cells. This makes it a promising candidate for developing targeted therapies for cancers that rely on BCL6 for their growth and resistance to treatment. Additionally, BI-3802 is used in preclinical studies to better understand the role of BCL6 in oncogenesis and to explore its potential in combination with other anticancer agents.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white Powder |
| PURITY | 98.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿48,000.00 |
+
-
|
| 0.010 | 10-20 days | ฿84,000.00 |
+
-
|
| 0.050 | 10-20 days | ฿225,000.00 |
+
-
|
BI-3802
BI-3802 is a small molecule inhibitor that targets BCL6, a transcriptional repressor involved in the regulation of gene expression. Its primary application is in cancer research and therapy, particularly for treating B-cell lymphomas. By inhibiting BCL6, BI-3802 disrupts the protein's ability to promote cancer cell survival and proliferation, leading to the induction of apoptosis in malignant cells. This makes it a promising candidate for developing targeted therapies for cancers that rely on BCL6 for their growth and resistance to treatment. Additionally, BI-3802 is used in preclinical studies to better understand the role of BCL6 in oncogenesis and to explore its potential in combination with other anticancer agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :